Rhumbline Advisers KINIKSA PHARMACEUTICALS INT Transaction History

Rhumbline Advisers

  • $109 Billion
  • Q4 2024
Number of Shares
58,955
Previous 59,864 1.52%
Holding current value
$0
Previous $0 NaN%
% of portfolio
0.0%
Previous 0.0%

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2024

Jan 30, 2025
SELL
N/A
-909 Reduced 1.52%
58,955 $0
Q3 2024

Nov 12, 2024
BUY
N/A
3,798 Added 6.77%
59,864 $0
Q2 2024

Aug 01, 2024
BUY
N/A
56,066 New
56,066 $0
Track This Portfolio

Track Rhumbline Advisers Portfolio

Follow Rhumbline Advisers and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Rhumbline Advisers, based on Form 13F filings with the SEC.

News

Stay updated on Rhumbline Advisers with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email